Logo do repositório
 
Publicação

Identification of a cytokine network sustaining neutrophil and Th17 activation in untreated early rheumatoid arthritis

dc.contributor.authorCascão, Rita
dc.contributor.authorMoura, Rita A.
dc.contributor.authorPerpétuo, Inês
dc.contributor.authorCanhao, Helena
dc.contributor.authorVieira-Sousa, Elsa
dc.contributor.authorMourão, Ana F.
dc.contributor.authorRodrigues, Ana M.
dc.contributor.authorPolido-Pereira, Joaquim
dc.contributor.authorQueiroz, Mário V.
dc.contributor.authorRosário, Henrique S.
dc.contributor.authorSouto-Carneiro, Maria M.
dc.contributor.authorGraca, Luis
dc.contributor.authorFonseca, João Eurico
dc.date.accessioned2012-05-21T15:46:26Z
dc.date.available2012-05-21T15:46:26Z
dc.date.issued2010
dc.description© 2010 Cascão et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.por
dc.description.abstractIntroduction: Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease characterized by sustained synovitis. Recently, several studies have proposed neutrophils and Th17 cells as key players in the onset and perpetuation of this disease. The main goal of this work was to determine whether cytokines driving neutrophil and Th17 activation are dysregulated in very early rheumatoid arthritis patients with less than 6 weeks of disease duration and before treatment (VERA). Methods: Cytokines related to neutrophil and Th17 activation were quantified in the serum of VERA and established RA patients and compared with other very early arthritis (VEA) and healthy controls. Synovial fluid (SF) from RA and osteoarthritis (OA) patients was also analyzed. Results: VERA patients had increased serum levels of cytokines promoting Th17 polarization (IL-1b and IL-6), as well as IL-8 and Th17-derived cytokines (IL-17A and IL-22) known to induce neutrophil-mediated inflammation. In established RA this pattern is more evident within the SF. Early treatment with methotrexate or corticosteroids led to clinical improvement but without an impact on the cytokine pattern. Conclusions: VERA patients already display increased levels of cytokines related with Th17 polarization and neutrophil recruitment and activation, a dysregulation also found in SF of established RA. 0 Thus, our data suggest that a cytokine-milieu favoring Th17 and neutrophil activity is an early event in RA pathogenesis.eng
dc.description.sponsorshipThis work was supported by a grant from Sociedade Portuguesa de Reumatologia/Schering-Plough 2005. RAM and RC were funded by Fundação para a Ciência e a Tecnologia (FCT) SFRH/BD/30247/2006 and SFRH/BD/40513/2007, respectively. MMS-C was funded by Marie Curie Intra-European Fellowship PERG-2008-239422 and a EULAR Young Investigator Award.eng
dc.identifier.citationArthritis Research & Therapy 2010, 12:R196eng
dc.identifier.issn1478-6354
dc.identifier.urihttp://hdl.handle.net/10451/6352
dc.identifier.uridoi:10.1186/ar3168
dc.identifier.urihttp://arthritis-research.com/content/12/5/R196
dc.language.isootherpor
dc.peerreviewedyespor
dc.publisherBioMed Centralpor
dc.subjectRheumatoid arthritiseng
dc.subjectCytokineseng
dc.subjectNeutrophileng
dc.subjectTh17eng
dc.titleIdentification of a cytokine network sustaining neutrophil and Th17 activation in untreated early rheumatoid arthritiseng
dc.typejournal article
dspace.entity.typePublication
oaire.citation.startPageR196por
oaire.citation.titleArthritis Research & Therapyeng
person.familyNameCanhao
person.familyNameSilva Graca
person.familyNameFonseca
person.givenNameHelena
person.givenNameLuis Ricardo
person.givenNameJoão
person.identifierB-8887-2008
person.identifier.ciencia-id6C19-B162-F561
person.identifier.ciencia-idF310-B85D-57C7
person.identifier.orcid0000-0002-3239-2809
person.identifier.orcid0000-0001-6935-8500
person.identifier.orcid0000-0003-1432-3671
person.identifier.scopus-author-id6602393492
person.identifier.scopus-author-id36138488700
person.identifier.scopus-author-id7101983519
rcaap.rightsopenAccesspor
rcaap.typearticlepor
relation.isAuthorOfPublication48f3be39-37f9-44de-9c7e-22e49a89efe5
relation.isAuthorOfPublication9da841d6-508a-484b-a61e-ee2fab2bc226
relation.isAuthorOfPublication1772dc12-7c55-4c76-ae2d-c23270172480
relation.isAuthorOfPublication.latestForDiscovery9da841d6-508a-484b-a61e-ee2fab2bc226

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
artigo.pdf
Tamanho:
714.66 KB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.2 KB
Formato:
Item-specific license agreed upon to submission
Descrição: